Phase 1 Trial of CAR-T Cell Therapy for Head and Neck Cancer – Cancer Therapy Advisor
Cancer Therapy Advisor |
Phase 1 Trial of CAR–T Cell Therapy for Head and Neck Cancer
Cancer Therapy Advisor Description: For this single-arm, phase 1 study (ClinicalTrials.gov Identifier: NCT01818323), researchers are evaluating whether patients with squamous cell cancer of the head and neck will respond to autologous T4+ positive T cells administered … |
